<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65836</article-id><article-id pub-id-type="doi">10.7554/eLife.65836</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-218970"><name><surname>Sabnis</surname><given-names>Akshay</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218957"><name><surname>Hagart</surname><given-names>Katheryn L H</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218971"><name><surname>Klöckner</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218972"><name><surname>Becce</surname><given-names>Michele</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218973"><name><surname>Evans</surname><given-names>Lindsay E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188661"><name><surname>Furniss</surname><given-names>R Christopher D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5806-5099</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171148"><name><surname>Mavridou</surname><given-names>Despoina A I</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218961"><name><surname>Murphy</surname><given-names>Ronan</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56610"><name><surname>Stevens</surname><given-names>Molly M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7335-266X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218963"><name><surname>Davies</surname><given-names>Jane C</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155801"><name><surname>Larrouy-Maumus</surname><given-names>Gérald J</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218974"><name><surname>Clarke</surname><given-names>Thomas B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-218965"><name><surname>Edwards</surname><given-names>Andrew M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7173-7355</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">MRC Centre for Molecular Bacteriology and Infection</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">MRC Centre for Molecular Bacteriology and Infection</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Life Sciences</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Department of Molecular Biosciences</institution>, <institution>University of Texas at Austin</institution>, <addr-line><named-content content-type="city">Austin</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">National Heart and Lung Institute</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff7"><institution content-type="dept">MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-21020"><name><surname>Cole</surname><given-names>Philip A</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>a.edwards@imperial.ac.uk</email> (AE);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>06</day><month>04</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e65836</elocation-id><history><date date-type="received"><day>16</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>31</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Sabnis et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Sabnis et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65836-v1.pdf"/><abstract><p>Colistin is an antibiotic of last resort, but has poor efficacy and resistance is a growing problem. Whilst it is well established that colistin disrupts the bacterial outer membrane by selectively targeting lipopolysaccharide (LPS), it was unclear how this led to bacterial killing. We discovered that MCR-1 mediated colistin resistance in<italic> Escherichia coli</italic> is due to modified LPS at the cytoplasmic rather than outer membrane. In doing so, we also demonstrated that colistin exerts bactericidal activity by targeting LPS in the cytoplasmic membrane. We then exploited this information to devise a new therapeutic approach. Using the LPS transport inhibitor murepavadin, we were able to cause LPS accumulation in the cytoplasmic membrane of <italic>Pseudomonas aeruginosa</italic>, which resulted in increased susceptibility to colistin <italic>in vitro</italic> and improved treatment efficacy <italic>in vivo</italic>. These findings reveal new insight into the mechanism by which colistin kills bacteria, providing the foundations for novel approaches to enhance therapeutic outcomes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>PhD Studentship</award-id><principal-award-recipient><name><surname>Sabnis</surname><given-names>Akshay</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Edwards</surname><given-names>Andrew M</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100013342</institution-id><institution>NIHR Imperial Biomedical Research Centre</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Edwards</surname><given-names>Andrew M</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>DFG</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Klöckner</surname><given-names>Anna</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Horizon 2020</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Klöckner</surname><given-names>Anna</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000833</institution-id><institution>Rosetrees Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Stevens</surname><given-names>Molly M</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000292</institution-id><institution>Cystic Fibrosis Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Davies</surname><given-names>Jane C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The use of mice was performed under the authority of the UK Home Office outlined in the Animals (Scientific Procedures) Act 1986 after ethical review by Imperial College London Animal Welfare and Ethical Review Body (PPL 70/7969).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Source data for all figures has been deposited at Dryad: https://doi.org/10.5061/dryad.98sf7m0hh</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Sabnis A</collab><collab>Hagart KLH</collab><collab>Klöckner A</collab><collab>Becce M</collab><collab>Evans LE</collab><collab>Furniss RCD</collab><collab>Mavridou DAi</collab><collab>Murphy R</collab><collab>Stevens MM</collab><collab>Davies JC</collab><collab>Larrouy-Maumus GJ</collab><collab>Clarke TB</collab><collab>Edwards AM</collab></person-group><year iso-8601-date="2021">2021</year><source>Data from: Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.98sf7m0hh">http://dx.doi.org/10.5061/dryad.98sf7m0hh</ext-link><comment>Dryad Digital Repository, doi: 10.5061/dryad.98sf7m0hh</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-65836-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>